ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. Igor Linkov, MSc, PhD US Army Engineer Research and Development Center (ERDC) and Carnegie Mellon University Pittsburgh, PA, USA.William Hynes, DPhil Organisation for Economic Cooperation and Development (OECD) Paris, France.Harris Eyre, MD, PhD Organisation for Economic Cooperation and Development (OECD)-PRODEO Institute Neuroscience-Inspired Policy Initiative Los Angeles, CA, USA.Pizzi, RPh, PharmD, MPH ISPOR Lawrenceville, NJ, USA
Ebere illustrate how to#
This ISPOR Signal event will discuss innovative approaches for understanding the complexity of people, human-made systems, economies, and societies, while exploring how to best ensure their adaptability, recovery, and resilience. Signal Episode: New Analytical Approaches to 21st Century Challenges Signal episodes feature topics and speakers that will shape healthcare decision making over the decade, while also addressing how HEOR can best contribute to solving healthcare’s greatest challenges.
Ebere illustrate series#
ISPOR 2022 is also presenting an episode of its Signal series at ISPOR 2022.
Speakers will explore how digital data can provide HTA organizations with direct use of real-world evidence. This plenary will consider how digital health data can be used to target access to health technologies for patients who would benefit most. Plenary 3: The Patient (Finally) at the Center: How Can We Leverage Digital Data to Make Patient-Focused Adoption, Reimbursement, and Management Decisions?
Michael Pencina, PhD Duke University School of Medicine Durham, NC, USA.Manski, PhD Northwestern University Evanston, IL, USA Bob Darin, MBA Blue Health Intelligence Chicago, IL, USA.Moderator: Ebere Onukwugha, MSc, PhD University of Maryland School of Pharmacy Baltimore, MD, USA.The session will also illustrate HEOR’s evolving and increasing role in addressing these issues. This plenary will discuss how healthcare decision makers can appropriately utilize healthcare data for probabilistic risk assessment, which is often employed for the successful application of big data analytics to personalized medicine. Plenary 2: Can Big Data Analytics Deliver on the Promises of Personalized Medicine for All? Unpacking the Health Equity Considerations Joseph Ross, MD, MHS Yale University New Haven, CT, USA.Douglas Kelly, MD US Food and Drug Administration Silver Spring, MD, USA.Noa Dagan, MD, PhD, MPH Clalit Health Services Tel Aviv, Israel.Balicer, MD, PhD, MPH Clalit Health Services Tel Aviv, Israel As these factors have forced HTA to occur “on the run,” the session will provide critical learnings about how to accelerate the introduction of new products and assess their impact on patients’ lives. This plenary will explore a series of case studies that present unique solutions to the health technology assessment (HTA) challenges that health authorities have been dealing with and that were fueled during the pandemic. Plenary 1: Health Technology Assessment on the Run ISPOR 2022 marks the Society’s first in-person conference in 2 years. ISPOR 2022 is scheduled for May 15-18 with the theme “The Future of HEOR in Patient-Driven Digital Healthcare Systems.” ISPOR 2022 is offering both in-person and virtual conference experience options for attendees with the in-person event being held in the Washington, DC, USA area. Newswise - Lawrenceville, NJ, USA-April 12, 2022- ISPOR -The Professional Society for Health Economics and Outcomes Research (HEOR) announced its plenary sessions and speakers for ISPOR 2022, the Society’s annual international conference. News Research News Releases Journal News Medical News Science News Life News Business News Expert Pitch Google Fact Check Research Alert Marketplace News With Video/Audio Multimedia RSS Feeds by Latest News Coronavirus News Currently Embargoed